六开窗覆膜支架用于IV型胸腹主动脉瘤修复的可行性与12个月通畅性
本病例报告描述一名62岁男性63毫米近肾主动脉瘤患者,因病史和免疫抑制治疗选择血管内修复,使用六开窗覆膜支架成功插管并支架置入4条肾动脉、肠系膜上动脉和腹腔干。围术期无肾功能损害等并发症,12个月随访肾功能未受损,内假体贴合良好、无内漏、开窗通畅且瘤径减小。六开窗支架用于涉及副肾动脉的近肾主动脉瘤可能可行,12个月通畅性适当。
要点
- 六开窗覆膜支架可同时保留4条肾动脉、肠系膜上动脉和腹腔干。
- 术后12个月无内漏、开窗通畅、瘤径减小且肾功能未受损。
- 覆盖副肾动脉可能相关肾梗死和肾功能损害,需谨慎评估。
核心结论
- 六开窗覆膜支架治疗涉及副肾动脉的近肾主动脉瘤可能可行,12个月通畅性适当。
研究设计与样本
- 病例报告:62岁男性,63毫米近肾主动脉瘤,因病史和持续免疫抑制治疗选择血管内修复。
主要发现
- 使用六开窗内假体成功插管并支架置入4条肾动脉、肠系膜上动脉和腹腔干。
- 围术期无肾功能损害等并发症。
- 12个月随访肾功能未受损,内假体贴合良好,无内漏,开窗通畅,瘤径减小。
关键数值与推荐
- 覆盖副肾动脉是近肾主动脉瘤血管内修复的既定必要技术,但可能与随访期肾梗死和肾功能损害相关。
临床怎么用
- 对于涉及副肾动脉的近肾主动脉瘤,六开窗FEVAR可作为保留多支内脏动脉的可行选择。
- 术后需随访肾功能、内漏、开窗通畅性和瘤径变化。
局限性
- 单病例报告,样本量小,结论需更大样本验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Fenestrated endovascular aortic aneurysm repair (FEVAR) is a standard procedure for the treatment of complex aortic aneurysm. More than 4 fenestrations are still randomly used, even in case of complex aneurysm anatomy involving accessory renal arteries. METHODS: We are presenting the case of a 62-year-old male patient suffering from 63-mm juxtarenal aortic aneurysm. Because of his medical history and an ongoing immunosuppressive medication an endovascular approach was conducted. Using a 6-fold fenestrated endograft, 4 renal arteries as well as the superior mesenteric artery and the celiac trunk have been cannulated and stented successfully. RESULTS: No perioperative complications such as impairment of renal function could be observed. After 12 months, still a nonhampered renal function could be assessed. Furthermore, the endoprosthesis showed a good fit without detection of endoleaks, patent fenestrations, and a decreasing aneurysm diameter after 12 months of follow-up. Coverage of accessory renal arteries has been described as an established and necessary technique during endovascular repair of juxtarenal aortic aneurysm; yet coverage of these vessels may be related to renal infarction and an impaired renal function during follow-up. Based on current technical developments the implantation of a 6-fold FEVAR may be conducted with promising results. CONCLUSIONS: Six-fold fenestrated stent-graft prosthesis for the treatment of juxtarenal aortic aneurysm involving accessory renal arteries may be a feasible treatment option related to an appropriate 12-month patency.
引用
- Kalder J, Gombert A, Kotelis D, et al. Feasibility and Twelve-month Patency of a Six-fold Fenestrated Stent Graft for Type IV Thoracoabdominal Aneurysm Repair. Ann Vasc Surg. 2019. PMID: 31195107. doi:10.1016/j.avsg.2019.03.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。